Evidence-Based Management of Anticoagulant Therapy
Anne Holbrook(McMaster University), Gordon Guyatt(Impact), Per Olav Vandvik(Nasjonalt Kunnskapssenter for Helsetjenesten), Mark Crowther(McMaster University), Sam Schulman(Hamilton General Hospital), David L. Veenstra(University of Washington), Michael J. Kovacs(Western University), Peter J. Svensson(Lund University), Jason Fish(University of California, Los Angeles), Daniel M. Witt(University of Utah)
Cited by 1,259
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k